A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder
A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.
Key wordsBrofaromine MAOI PTSD Psychopharmacology
Unable to display preview. Download preview PDF.
- Blake D, Weathers F, Nagy L, Kaloupeck D, Klauminzer D, Charney DS, Keane TM (1990). A clinician rating scale for assessing current and lifetime PTSD: the CAPS 1. Behav Ther 18:187–188Google Scholar
- Breslau N, Davis GC, Andreski P et al. (1991) Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 48:212–218Google Scholar
- Van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G (1994) Fluoxetine treatment in post traumatic stress disorder. J Clin Psychiatry 55:517–522Google Scholar